Novo Will Never Beat Lilly. Why Does It Have To?

Novo Nordisk and Eli Lilly have been battling head-to-head in an exploding obesity market. They should never have been compared apples to apples.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top